George A. Digenis, Ph.D. - University of Kentucky - College of ...

"Latest News on Small Intestinal Transit Time", 1993 Capsugel Symposium, Nagai Memorial
Hall, Shibuya, Tokyo, Japan, May 10, 1993.
"The Use of Gamma Scintigraphy to Establish Product Claims and Explain Oral Drug
Absorption Anomalies", 33rd Associazione Farmaceutici Industria Symposium, Le Conchiglie
Congress Centre, Riccione, Italy, June 2-4, 1993.
"Gamma Scintigraphy and Neutron Activation Techniques in the in-vivo Assessment of Orally
Administered Dosage Forms", Center for Drug Evaluation and Research, Food and Drug
Administration, Rockville, Maryland, November 2, 1993.
JAGO, Vienna, Austria, "A Novel Oral Controlled Release Drug Delivery System with Gastric
Retentive Properties", May 2-3, 1994.
Capsugel Board of Advisors Meeting, Rome, Italy, "Chemistry of Gelatin Cross-linking", May
4-6, 1994.
Sixth Cyprus Conference on New Methods in Drug Research, Limassol, Cyprus, "Current
Advances in Drug Targeting to the GI Tract", May 7-14, 1994.
Controlled Release Society, Nice, France, "Comparative Scintigraphic Evaluation of Aromatic-
Azo Polymers and Eudragit (R) S-100 for Colonic Release in beagles", June 24-July 1, 1994.
Second European Pharmaceutical Technology Conference, Barcelona, Spain, "Current Status
on Oral Solid-Dosage Forms of Peptides: Biological and Formulation Factors", October 18-19,
1994.
FDA, Rockville, MD, "Cross-Linking of Gelatin Capsules", December 1, 1994.
"Defining Variable Oral Absorption by Concomitant Evaluation of GI Transit Using
Pharmacoscintigraphy", American Association of Pharmaceutical Scientists/FDA Workshop
on Evaluation of Orally Administered Highly Variable Drugs and Drug Formulations,
Arlington, VA, March 5-8, 1995.
"Development of a Novel Controlled Release Formulation of Nonoxynol-9 and Oligomers"
University of Athens, College of Pharmacy, Athens, Greece, May, 1995.
"The Role of Pharmacoscintigraphy in the Assessment of the in vivo Behavior of Drug
Formulations", University of Athens, College of Pharmacy, Athens, Greece, May, 1955.
"The Role of Rhinoscintigraphy in Nasal Drug Delivery", present at Focus Group Meeting,
November 7, 1995, Miami Beach Convention Center, Miami, FL.
"New Approaches for the Design of Antacid Formulations", September 7, 1995, Warner-
Lambert Company, Morris Plaines, NJ.
"Biopharmaceutical Drug Classification and International Drug Regulation", Capsugel/FDA,
Princeton, NJ, May 17, 1995.
"Assessment of Behavior of Oral Dosage Forms by Gamma Scintigraphy", Merck
Frosst Canada, Inc., Dorval, Quebec, Canada, September 1, 1995.
Participant as a member of the panel which discussed the Biopharmaceutics Drug
Classification and International Drug Regulation - organized by Capsugel, May 17, 1995.
Presented mini-course on oral drug delivery, presented to Graduate Students and Staff,
University of Athens, College of Pharmacy, Athens, Greece, May, 1995.
Review of proposals (Review RFP NICHD-CD-95-8) "Female Controlled Methods -
Development of Novel Vaginal Products to Maintain the Integrity of the Vaginal Ecosystem",
July 11, 1995.
14